Page last updated: 2024-10-27

foscarnet and Combined Immunodeficiency, X-Linked

foscarnet has been researched along with Combined Immunodeficiency, X-Linked in 1 studies

Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iwasenko, JM1
Scott, GM1
Ziegler, JB1
Rawlinson, WD1

Other Studies

1 other study available for foscarnet and Combined Immunodeficiency, X-Linked

ArticleYear
Emergence and persistence of multiple antiviral-resistant CMV strains in a highly immunocompromised child.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2007, Volume: 40, Issue:2

    Topics: Antiviral Agents; Child; Cytomegalovirus; Cytomegalovirus Infections; Drug Monitoring; Drug Resistan

2007